Matt Schissler, CEO of Cord Blood America (CBAI.OB) said in an interview with the Wall Street Transcript
“At the University of Florida right now, there is a study going on to see if umbilical cord blood stem cells can treat and cure juvenile diabetes.
“If that does get through trials and end up becoming commercialized, there is a much larger population that has a history of diabetes in the family than they do cancer and leukemia.
“Now you're going to have a much larger population saying, "Okay, this might be a good idea for us to store stem cells" and we believe that's going to be the next tipping point.
“ I think over the next three to ten years you're going to see many new therapies get to market and as those therapies get to market, those therapies are going to affect more and more families and you're going to start seeing a much higher percentage of family storing their stem cells.”
IPOdesktop CBAI Analyst Report